Science Explorer Back to mapMap
Discussion
Company · Raleigh · United States

Collaborations Pharmaceuticals (United States)

collaborationspharma.comROR OpenAlex
World rank, all time
#24,644
of 34,923
Rank in United States
#5,131
of 7,310
Research works
146
▲ 51% vs 2018-21
Citations
4.1k
28.2 per fractional work
Top-10% rate
13.7%
all institutions 10.0%
vs its own fields
1.23×
1.00× is exactly expected
Open access
69%
world 40%
International
19%
world 18%
Collaborations Pharmaceuticals (United States)

Which fields of science does Collaborations Pharmaceuticals (United States) work in?

In 2022-now, 37% of research at Collaborations Pharmaceuticals (United States) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (16%), Computer Science (13%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 23 fractional works · 36.7% of its workMedicine: 22 fractional works · 36.1% of its workInfectious Diseases: 6 fractional works · 9.3% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 7.3% of its workEpidemiology: 2 fractional works · 3.1% of its workPharmacology: 2 fractional works · 3.0% of its workOncology: 2 fractional works · 2.6% of its workPhysiology: 1 fractional works · 2.4% of its workReproductive Medicine: 1 fractional works · 1.9% of its workComplementary and alternative medicine: 1 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.1% of its workGenetics: 0 fractional works · 0.5% of its workHealth Informatics: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.5% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.6% of its workSmall Animals: 0 fractional works · 0.6% of its workLife Sciences: 17 fractional works · 27.3% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 16.2% of its workMolecular Biology: 6 fractional works · 10.0% of its workGenetics: 2 fractional works · 2.6% of its workBiophysics: 1 fractional works · 1.4% of its workCell Biology: 1 fractional works · 0.9% of its workCancer Research: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 4.4% of its workPharmacology: 2 fractional works · 3.3% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workToxicology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 2 fractional works · 2.8% of its workPlant Science: 1 fractional works · 1.7% of its workInsect Science: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.3% of its workAgronomy and Crop Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 1 fractional works · 2.3% of its workImmunology: 1 fractional works · 1.3% of its workVirology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysical Sciences: 14 fractional works · 22.4% of its workComputer Science: 8 fractional works · 12.6% of its workComputational Theory and Mathematics: 6 fractional works · 9.3% of its workArtificial Intelligence: 2 fractional works · 3.2% of its workEnvironmental Science: 2 fractional works · 3.6% of its workEcology: 1 fractional works · 1.6% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 1.1% of its workPollution: 1 fractional works · 0.9% of its workMaterials Science: 2 fractional works · 3.0% of its workMaterials Chemistry: 2 fractional works · 3.0% of its workChemistry: 1 fractional works · 1.5% of its workOrganic Chemistry: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 1.3% of its workBiomedical Engineering: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.5% of its workModeling and Simulation: 0 fractional works · 0.5% of its workSocial Sciences: 8 fractional works · 13.5% of its workDecision Sciences: 3 fractional works · 4.7% of its workStatistics, Probability and Uncertainty: 2 fractional works · 2.4% of its workInformation Systems and Management: 1 fractional works · 2.2% of its workSocial Sciences: 2 fractional works · 3.2% of its workSociology and Political Science: 1 fractional works · 1.1% of its workTransportation: 1 fractional works · 1.1% of its workGeography, Planning and Development: 0 fractional works · 0.5% of its workSafety Research: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.9% of its workEconomics and Econometrics: 1 fractional works · 1.9% of its workArts and Humanities: 1 fractional works · 1.6% of its workHistory and Philosophy of Science: 1 fractional works · 1.6% of its workBusiness, Management and Accounting: 1 fractional works · 1.6% of its workManagement Information Systems: 1 fractional works · 1.6% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workALL ITS WORKCollaborationsPharmaceuticals…62fractional works, 2022-now
Life Sciences27%Physical Sciences22%Health Sciences37%Social Sciences14%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine2236.1%
    2. Veterinary00.6%
    1. Biochemistry, Genetics and Molecular Biology1016.2%
    2. Pharmacology, Toxicology and Pharmaceutics34.4%
    3. Agricultural and Biological Sciences22.8%
    4. Immunology and Microbiology12.3%
    5. Neuroscience11.6%
    1. Computer Science812.6%
    2. Environmental Science23.6%
    3. Materials Science23.0%
    4. Chemistry11.5%
    5. Engineering11.3%
    6. Mathematics00.5%
    1. Decision Sciences34.7%
    2. Social Sciences23.2%
    3. Economics, Econometrics and Finance11.9%
    4. Arts and Humanities11.6%
    5. Business, Management and Accounting11.6%
    6. Psychology00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.59× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.05× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 2.27× its world share, 1 worksImmunology and Micro…Neuroscience: 0.97× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 12.44× its world share, 3 worksPharmacology, Toxico…Chemistry: 0.98× its world share, 1 worksChemistryComputer Science: 1.61× its world share, 8 worksComputer ScienceEngineering: 0.08× its world share, 1 worksEngineeringEnvironmental Science: 0.72× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.85× its world share, 2 worksMaterials ScienceMathematics: 0.46× its world share, 0 worksMathematicsMedicine: 1.88× its world share, 22 worksMedicineVeterinary: 4.62× its world share, 0 worksVeterinaryArts and Humanities: 0.56× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.50× its world share, 1 worksBusiness, Management…Decision Sciences: 4.80× its world share, 3 worksDecision SciencesEconomics, Econometrics and Finance: 0.88× its world share, 1 worksEconomics, Econometr…Psychology: 0.18× its world share, 0 worksPsychologySocial Sciences: 0.26× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.4×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics12.44×3 works
  2. Decision Sciences4.80×3 works
  3. Veterinary4.62×0 works
  4. Biochemistry, Genetics and Molecular Biology3.05×10 works
  5. Immunology and Microbiology2.27×1 works
  6. Medicine1.88×22 works
  7. Computer Science1.61×8 works
  8. Chemistry0.98×1 works
  9. Neuroscience0.97×1 works
  10. Economics, Econometrics and Finance0.88×1 works
  11. Materials Science0.85×2 works
  12. Environmental Science0.72×2 works
  13. Agricultural and Biological Sciences0.59×2 works
  14. Arts and Humanities0.56×1 works
  15. Business, Management and Accounting0.50×1 works
  16. Mathematics0.46×0 works
  17. Social Sciences0.26×2 works
  18. Psychology0.18×0 works
  19. Engineering0.08×1 works

Who are the top researchers at Collaborations Pharmaceuticals (United States)?

Ranked on the quality score, Sean Ekins, Kimberley M. Zorn and Thomas R. Lane lead among researchers whose main affiliation is Collaborations Pharmaceuticals (United States).

  1. 1 Sean Ekins United States · #166,078 worldwide 23k citations · 733 works
  2. 2 Kimberley M. Zorn United States · #225,808 worldwide 2.5k citations · 62 works
  3. 3 Thomas R. Lane United States · #252,975 worldwide 2.7k citations · 125 works
  4. 4 Fabio Urbina United States · #569,078 worldwide 1.3k citations · 70 works
  5. 5 Daniel H. Foil United States · #569,994 worldwide 1.3k citations · 48 works
  6. 6 Alex M. Clark United States · #702,724 worldwide 3.3k citations · 143 works
  7. 7 Ana C. Puhl United States · #829,191 worldwide 2.8k citations · 91 works
  8. 8 Scott H. Snyder United States · #1,529,781 worldwide 162 citations · 17 works
  9. 9 Renuka Raman United States · #1,618,894 worldwide 615 citations · 43 works
  10. 10 Patricia A. Vignaux United States · #1,774,782 worldwide 201 citations · 25 works
All ranked researchers at Collaborations Pharmaceuticals (United States)

What are the most cited papers from Collaborations Pharmaceuticals (United States)?

The most cited paper from Collaborations Pharmaceuticals (United States) is "Exploiting machine learning for end-to-end drug discovery and development" (Sean Ekins, Ana C. Puhl, Kimberley M. Zorn et al., 2019), with 606 citations. Next come "Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets" (368) and "Dual use of artificial-intelligence-powered drug discovery" (343).

Most cited papers
#PaperReleasedCitations
1 Exploiting machine learning for end-to-end drug discovery and development Sean Ekins, Ana C. Puhl, Kimberley M. Zorn et al. · Nature Materials Open access 18 Apr 2019 606
2 Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets Alexandru V. Korotcov, Valery Tkachenko, Daniel P. Russo et al. · Molecular Pharmaceutics Open access 3 Nov 2017 368
3 Dual use of artificial-intelligence-powered drug discovery Fabio Urbina, Filippa Lentzos, Cédric F. Invernizzi et al. · Nature Machine Intelligence Open access 7 Mar 2022 343
4 In silico repositioning of approved drugs for rare and neglected diseases Sean Ekins, Antony John Williams, Matthew David Krasowski et al. · Drug Discovery Today Open access 7 Mar 2011 296
5 The Next Era: Deep Learning in Pharmaceutical Research Sean Ekins · Pharmaceutical Research Open access 6 Sep 2016 240
All 60 most cited papers, with filters and sorting

Which keywords describe research at Collaborations Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Pharmacokinetics, Machine Learning, Medicinal Chemistry, Molecular Docking, Virtual Screening, Pandemic, Vaccine and ACE2 Receptor.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Machine Learning10▲ 4.6×6 topics
  2. Pharmacokinetics8▲ 48×3 topics
  3. Medicinal Chemistry6▲ 36×2 topics
  4. Molecular Docking6▲ 76×1 topic
  5. Virtual Screening6▲ 103×1 topic
  6. Pandemic6▲ 8.9×4 topics
  7. Epidemiology5▲ 2.1×19 topics
  8. Vaccine4▲ 18×7 topics
  9. ACE2 Receptor4▲ 28×2 topics
  10. SARS-CoV-24▲ 21×2 topics
  11. Immunity3▲ 13×4 topics
  12. Viral Transmission3▲ 37×2 topics
  13. Immune Response3▲ 8.4×8 topics
  14. Coronavirus3▲ 23×1 topic
  15. spike protein3▲ 47×1 topic
  16. Big Data3▲ 4.6×4 topics
  17. Drug Development3▲ 49×2 topics
  18. Capacity Building2▲ 67×3 topics
  19. Genetic Variation2▲ 18×3 topics
  20. Drug Resistance2▲ 13×5 topics
  21. Genomics2▲ 13×3 topics
  22. Data Mining2▲ 4.8×2 topics
  23. Interdisciplinary Research2▲ 38×2 topics
  24. Alzheimer's Disease2▲ 12×2 topics
  25. Cytochrome P4502▲ 98×1 topic
  26. Medical Research2▲ 116×1 topic
  27. Pharmacogenetics2▲ 160×1 topic
  28. Physician-Scientist2▲ 116×1 topic
  29. Precision Medicine2▲ 6.5×3 topics
  30. Ethical Considerations2▲ 8.8×3 topics
  31. Molecular Dynamics2▲ 18×2 topics
  32. Parkinson's Disease2▲ 12×3 topics
  33. High-Throughput2▲ 50×1 topic
  34. Materials Informatics2▲ 50×1 topic
  35. Pesticides2▲ 42×3 topics
  36. Pharmacology2▲ 12×4 topics
  37. Nuclear Receptors2▲ 31×4 topics
  38. Peer Review2▲ 79×3 topics
  39. Neurodegenerative Diseases2▲ 16×3 topics
  40. Toxicology2▲ 15×2 topics

Which research topics does Collaborations Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Computational Drug Discovery Methods, SARS-CoV-2 and COVID-19 Research, Pharmacogenetics and Drug Metabolism and Health and Medical Research Impacts.

Computational Drug Disco…6Computational Drug Discovery Methods: 6 fractional worksSARS-CoV-2 and COVID-19 …3SARS-CoV-2 and COVID-19 Research: 3 fractional worksPharmacogenetics and Dru…2Pharmacogenetics and Drug Metabolism: 2 fractional worksHealth and Medical Research Impacts: 2 fractional worksMachine Learning in Materials Science: 2 fractional worksLysosomal Storage Disord…2Lysosomal Storage Disorders Research: 2 fractional worksscientometrics and bibliometrics research: 2 fractional worksCholinesterase and Neurodegenerative Diseases: 1 fractional worksScience, Research, and Medicine: 1 fractional worksGenetics, Bioinformatics, and Biomedical Research: 1 fractional works
Computational Theory and MathematicsInfectious DiseasesPharmacologyPublic Health, Environmental and Occupational Health5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 6 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
  3. 3 Pharmacogenetics and Drug Metabolism Pharmacology 2 works
  4. 4 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 2 works
  5. 5 Machine Learning in Materials Science Materials Chemistry 2 works
  6. 6 Lysosomal Storage Disorders Research Physiology 2 works
  7. 7 scientometrics and bibliometrics research Statistics, Probability and Uncertainty 2 works
  8. 8 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
  9. 9 Science, Research, and Medicine Reproductive Medicine 1 works
  10. 10 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.9%not open31.1%

World: 40% of research is openly available.

with international co-authors19.4%domestic only80.6%

World: 18% is written across borders.

How has Collaborations Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 51% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Collaborations Pharmaceuticals (United States) as a percentage of every work published that year, 0.00020% in 2024.

still counting0.00020%0.00040%0.00060%Collaborations Pharmaceuticals (United States)0.00022% in 202520102020

Fractional works of Collaborations Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Raleigh

All research institutions in Raleigh

Share Collaborations Pharmaceuticals (United States)'s ranking

Collaborations Pharmaceuticals (United States) on Science Explorer

A card with Collaborations Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Collaborations Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.